chr10-112950260-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBA1
The NM_001367943.1(TCF7L2):c.-497G>T variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0304 in 186,790 control chromosomes in the GnomAD database, including 309 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.037 ( 291 hom., cov: 26)
Exomes 𝑓: 0.011 ( 18 hom. )
Consequence
TCF7L2
NM_001367943.1 5_prime_UTR
NM_001367943.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.00
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 10-112950260-G-T is Benign according to our data. Variant chr10-112950260-G-T is described in ClinVar as [Benign]. Clinvar id is 1222749.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.122 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCF7L2 | NM_001367943.1 | c.-497G>T | 5_prime_UTR_variant | 1/15 | ENST00000355995.9 | NP_001354872.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCF7L2 | ENST00000355995 | c.-497G>T | 5_prime_UTR_variant | 1/15 | 1 | NM_001367943.1 | ENSP00000348274.4 |
Frequencies
GnomAD3 genomes AF: 0.0364 AC: 5181AN: 142276Hom.: 288 Cov.: 26
GnomAD3 genomes
AF:
AC:
5181
AN:
142276
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0107 AC: 477AN: 44440Hom.: 18 Cov.: 0 AF XY: 0.0104 AC XY: 221AN XY: 21226
GnomAD4 exome
AF:
AC:
477
AN:
44440
Hom.:
Cov.:
0
AF XY:
AC XY:
221
AN XY:
21226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0366 AC: 5204AN: 142350Hom.: 291 Cov.: 26 AF XY: 0.0361 AC XY: 2466AN XY: 68338
GnomAD4 genome
AF:
AC:
5204
AN:
142350
Hom.:
Cov.:
26
AF XY:
AC XY:
2466
AN XY:
68338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
36
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 15, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at